NESTED NATURALS INC. – Trademark Portfolio
Entity Type: 03
NESTED NATURALS INC. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include LUNA, NESTED, and NESTED NATURALS. The owner is based in Vancouver, BC.
301-525 Seymour St
Vancouver, BC V6B3H7 , CA
Showing of trademarks Trademarks
Trademark Classifications
NESTED NATURALS INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does NESTED NATURALS INC. have?
NESTED NATURALS INC. has 16 U.S. trademarks filed with the USPTO. Of these, 6 registered, 8 abandoned, 2 cancelled.
What trademark classes does NESTED NATURALS INC. file in?
NESTED NATURALS INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NESTED NATURALS INC.'s most well-known trademarks?
NESTED NATURALS INC.'s registered trademark portfolio includes well-known marks such as LUNA, NESTED, and NESTED NATURALS. These are among 6 currently registered trademarks in the portfolio.
What is NESTED NATURALS INC.'s trademark registration success rate?
NESTED NATURALS INC. has a 38% trademark registration rate, with 6 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.